| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
13,639 |
12,540 |
$2.94M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
25,281 |
23,420 |
$1.87M |
| G0378 |
Hospital observation service, per hour |
3,987 |
2,410 |
$806K |
| 80053 |
Comprehensive metabolic panel |
26,767 |
21,514 |
$594K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
12,060 |
10,239 |
$579K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,773 |
1,651 |
$469K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,785 |
3,229 |
$439K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
38,332 |
27,875 |
$423K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,856 |
2,591 |
$270K |
| 71045 |
Radiologic examination, chest; single view |
10,360 |
9,026 |
$257K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,704 |
3,293 |
$218K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,185 |
2,283 |
$206K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,109 |
1,021 |
$178K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
5,562 |
1,487 |
$165K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,652 |
2,285 |
$153K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
3,125 |
2,864 |
$148K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,781 |
3,468 |
$141K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
375 |
328 |
$140K |
| 84703 |
|
11,674 |
10,703 |
$117K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,820 |
2,343 |
$107K |
| 83880 |
|
3,368 |
2,893 |
$105K |
| 81001 |
|
13,306 |
11,961 |
$99K |
| 84484 |
|
9,406 |
6,258 |
$97K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
223 |
188 |
$94K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,021 |
3,573 |
$93K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,039 |
958 |
$91K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,309 |
2,121 |
$83K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,484 |
3,175 |
$82K |
| 84702 |
|
4,093 |
3,601 |
$80K |
| 83690 |
|
8,460 |
7,564 |
$74K |
| 76801 |
|
693 |
620 |
$70K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
606 |
553 |
$67K |
| 71046 |
Radiologic examination, chest; 2 views |
1,795 |
1,708 |
$61K |
| 80050 |
General health panel |
360 |
325 |
$46K |
| 84145 |
|
2,093 |
1,801 |
$41K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
178 |
104 |
$40K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
949 |
905 |
$37K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
946 |
902 |
$37K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,029 |
840 |
$35K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,871 |
3,863 |
$34K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
420 |
354 |
$34K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
826 |
694 |
$34K |
| 83605 |
|
3,437 |
2,480 |
$33K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
180 |
166 |
$33K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
729 |
695 |
$30K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,515 |
2,532 |
$28K |
| 86850 |
|
1,693 |
1,552 |
$28K |
| 80320 |
|
1,904 |
1,606 |
$27K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
108 |
86 |
$27K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
737 |
687 |
$27K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
233 |
208 |
$25K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
222 |
187 |
$25K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,559 |
1,404 |
$24K |
| 87040 |
|
3,021 |
1,381 |
$23K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,989 |
2,720 |
$22K |
| 83735 |
|
5,451 |
3,061 |
$22K |
| 80069 |
|
4,360 |
2,285 |
$21K |
| 80143 |
|
979 |
839 |
$21K |
| 93976 |
|
237 |
206 |
$20K |
| 80179 |
|
889 |
772 |
$18K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
319 |
293 |
$18K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,208 |
1,121 |
$17K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
7,945 |
7,076 |
$16K |
| 82550 |
|
3,001 |
2,567 |
$16K |
| 73030 |
|
522 |
466 |
$15K |
| 85730 |
|
3,226 |
2,795 |
$14K |
| 81003 |
|
3,817 |
3,322 |
$14K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,887 |
1,616 |
$14K |
| 85610 |
|
4,590 |
3,761 |
$14K |
| G0257 |
Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility |
112 |
64 |
$13K |
| 73564 |
|
311 |
268 |
$12K |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
1,054 |
777 |
$12K |
| 93971 |
|
111 |
101 |
$12K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,422 |
5,574 |
$11K |
| 73610 |
|
314 |
289 |
$11K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
2,905 |
1,085 |
$11K |
| 90715 |
|
535 |
517 |
$11K |
| 86769 |
|
329 |
294 |
$10K |
| 72100 |
|
250 |
247 |
$10K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
152 |
148 |
$9K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
81 |
79 |
$8K |
| 82803 |
|
513 |
424 |
$8K |
| 85379 |
|
953 |
836 |
$8K |
| 73630 |
|
227 |
192 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
896 |
819 |
$7K |
| 87186 |
|
1,023 |
949 |
$7K |
| 97162 |
|
81 |
69 |
$7K |
| 86900 |
|
2,596 |
2,164 |
$6K |
| 86901 |
|
2,587 |
2,163 |
$6K |
| 73590 |
|
252 |
211 |
$6K |
| 84100 |
|
2,390 |
1,534 |
$6K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
152 |
148 |
$6K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,759 |
3,363 |
$5K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
105 |
41 |
$5K |
| 80061 |
Lipid panel |
563 |
513 |
$5K |
| 80047 |
|
582 |
534 |
$4K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
4,393 |
3,374 |
$4K |
| 71250 |
|
40 |
37 |
$4K |
| 73562 |
|
103 |
92 |
$4K |
| 82728 |
|
471 |
390 |
$4K |
| 76830 |
Ultrasound, transvaginal |
37 |
36 |
$4K |
| 72131 |
|
38 |
36 |
$4K |
| 73502 |
|
127 |
123 |
$4K |
| 87210 |
|
619 |
588 |
$4K |
| 87340 |
|
703 |
610 |
$4K |
| 87081 |
|
516 |
497 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,445 |
2,203 |
$4K |
| 86140 |
|
990 |
798 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
53 |
51 |
$4K |
| 83721 |
|
544 |
495 |
$3K |
| 73130 |
|
78 |
70 |
$3K |
| 73552 |
|
125 |
115 |
$3K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
118 |
83 |
$3K |
| 94060 |
|
31 |
30 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
29 |
26 |
$2K |
| J1644 |
Injection, heparin sodium, per 1000 units |
2,083 |
851 |
$2K |
| 72170 |
|
85 |
80 |
$2K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,842 |
1,189 |
$2K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
15 |
13 |
$2K |
| 94644 |
|
40 |
38 |
$2K |
| 80076 |
|
263 |
239 |
$2K |
| 87077 |
|
357 |
338 |
$2K |
| 90686 |
|
119 |
115 |
$2K |
| 85018 |
|
765 |
606 |
$2K |
| 82553 |
|
167 |
160 |
$2K |
| 70486 |
|
13 |
13 |
$2K |
| 85014 |
|
1,081 |
927 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
7,444 |
6,174 |
$1K |
| 94726 |
|
14 |
14 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,690 |
2,454 |
$1K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
57 |
27 |
$1K |
| 97116 |
|
48 |
25 |
$1K |
| 83615 |
|
265 |
223 |
$1K |
| 87088 |
|
195 |
186 |
$1K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
227 |
202 |
$1K |
| J1940 |
Injection, furosemide, up to 20 mg |
608 |
252 |
$1K |
| J1790 |
Injection, droperidol, up to 5 mg |
285 |
262 |
$1K |
| 82570 |
|
715 |
476 |
$1K |
| 87807 |
|
31 |
30 |
$1K |
| 94664 |
|
2,181 |
1,234 |
$977.64 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,475 |
1,317 |
$972.72 |
| 94729 |
|
16 |
16 |
$952.02 |
| 96367 |
|
28 |
27 |
$888.23 |
| 82800 |
|
228 |
210 |
$855.74 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
633 |
468 |
$806.79 |
| 73110 |
|
13 |
12 |
$737.73 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,452 |
2,163 |
$635.24 |
| 73560 |
|
20 |
15 |
$590.49 |
| 80197 |
|
473 |
237 |
$575.31 |
| 72040 |
|
12 |
12 |
$530.48 |
| 84156 |
|
458 |
284 |
$513.65 |
| J3490 |
Unclassified drugs |
1,916 |
1,391 |
$512.29 |
| J1953 |
Injection, levetiracetam, 10 mg |
21 |
13 |
$510.02 |
| 86703 |
|
18 |
13 |
$482.95 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
9,153 |
2,462 |
$470.09 |
| 84443 |
Thyroid stimulating hormone (TSH) |
44 |
39 |
$464.87 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
12 |
12 |
$460.02 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
556 |
451 |
$429.88 |
| 82565 |
|
136 |
124 |
$379.10 |
| 90685 |
|
51 |
48 |
$360.18 |
| 82947 |
|
241 |
222 |
$342.01 |
| 87070 |
|
51 |
41 |
$324.75 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
17 |
13 |
$287.33 |
| 85651 |
|
79 |
67 |
$277.14 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
15 |
15 |
$274.18 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
58 |
42 |
$273.77 |
| J2060 |
Injection, lorazepam, 2 mg |
518 |
385 |
$268.04 |
| 80051 |
|
45 |
42 |
$253.73 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
144 |
132 |
$230.75 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
55 |
49 |
$211.95 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
821 |
768 |
$209.35 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,018 |
913 |
$208.18 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
532 |
454 |
$206.40 |
| 82962 |
|
14,690 |
3,624 |
$191.65 |
| 87205 |
|
53 |
42 |
$181.25 |
| 87075 |
|
31 |
27 |
$178.59 |
| 82150 |
|
30 |
27 |
$172.71 |
| 86592 |
|
16 |
12 |
$163.86 |
| 82607 |
|
17 |
12 |
$159.46 |
| Q9950 |
Injection, sulfur hexafluoride lipid microspheres, per ml |
15 |
12 |
$138.57 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
15 |
14 |
$131.70 |
| 84520 |
|
46 |
43 |
$128.67 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
156 |
110 |
$65.73 |
| C1769 |
Guide wire |
358 |
300 |
$63.82 |
| 83550 |
|
16 |
13 |
$51.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
31 |
28 |
$46.16 |
| 83540 |
|
15 |
13 |
$37.72 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
104 |
78 |
$36.65 |
| 82374 |
|
50 |
43 |
$29.41 |
| 84132 |
|
65 |
56 |
$22.43 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
26 |
19 |
$22.21 |
| J2704 |
Injection, propofol, 10 mg |
994 |
839 |
$20.67 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
31 |
24 |
$19.32 |
| 36415 |
Collection of venous blood by venipuncture |
1,450 |
1,187 |
$18.13 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
369 |
319 |
$14.00 |
| 84295 |
|
37 |
30 |
$7.38 |
| 96376 |
|
845 |
722 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
29 |
24 |
$0.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
15 |
15 |
$0.00 |
| 88738 |
|
15 |
15 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
24 |
12 |
$0.00 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
13 |
12 |
$0.00 |
| J0688 |
Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg |
15 |
15 |
$0.00 |